Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Secondary Alcohol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106892936B details a novel route for secondary trifluoromethyl propargyl alcohol, offering improved stability and supply chain reliability for pharmaceutical intermediates.
Patent CN115385774B enables mild condition high yield synthesis for electronic chemical manufacturing supply chain optimization and cost reduction.
Patent CN100554403C reveals Microbacterium oxydans for high-purity chiral alcohol. Offers cost reduction and supply chain reliability for pharma intermediates.
Patent CN112876355B reveals a novel Co-N-C catalyzed route for converting secondary alcohols to esters via C-C bond cleavage, offering superior yields and greener processing for pharmaceutical supply chains.
Patent CN101085990A reveals chemo-enzymatic route for high-purity chiral alcohols. Enables cost reduction and supply chain reliability for pharmaceutical intermediates.
Analysis of patent CN101085990B reveals a chemo-enzymatic route for high-purity chiral alcohols. This method offers significant supply chain stability and cost reduction advantages for pharmaceutical intermediate manufacturing.
Patent CN103044193B reveals a room-temperature zinc-catalyzed method for chiral secondary alcohols, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN1622932A details a novel ruthenium catalyst for efficient chiral alcohol resolution. Enables cost reduction in pharmaceutical manufacturing via simplified purification.
Patent CN1376659A reveals a safe metal borohydride reduction system for high-purity chiral intermediates, offering significant cost and supply chain advantages.
Patent CN117567288A details a novel asymmetric hydrogenation process for chiral alcohols, offering significant cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN116323522B reveals a base-free ruthenium catalyst enabling stable, scalable production of optically active secondary alcohols with superior cost efficiency.
Novel room-temperature asymmetric catalysis for chiral secondary aryl alcohols. Reduces cost by eliminating noble metals. High yield and ee for pharma intermediates.
Patent CN101314559B details a low-cost kinetic resolution method for aromatic chiral secondary alcohols using Boc-Proline, offering high purity for pharma intermediates.
Patent CN112675920B reveals a novel Ruthenium catalyst for efficient chiral alcohol synthesis. Discover cost reduction in pharmaceutical intermediate manufacturing and scalable production methods.
Patent CN100389877C details a novel PEG-supported ruthenium catalyst enabling ambient pressure asymmetric hydrogenation, offering significant cost reduction and supply chain reliability for API manufacturing.